VANCOUVER, Sept. 29 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO), a reprofiling company focused on redosing or reformulating drugs with clinical history for new or expanded indications, is pleased to announce that iCo will present at the BioContact Québec 2008 conference.
